-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $52

Benzinga·03/20/2026 17:44:19
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $37 to $52.